Galileo
Latest round
- Series A
Last raised
- May 2019
Total raised
- Undisclosed
Investors
- 1
About Galileo
Galileo, Inc.Founded in 2018 and headquartered in New York, US, Galileo, Inc. specializes in healthcare services. The company was founded in 2018 by Dr. Thomas X. Lee. Galileo offers a healthcare service model integrating digital and in-home care. Their core product is a comprehensive platform providing 24/7 access to healthcare professionals via mobile devices for a wide range of medical needs, including urgent care and chronic health management.Galileo's revenue model is based on partnerships with employers and health plans, utilizing a subscription service structure for healthcare access. Their approach emphasizes proactive health management, generating revenue from membership plans paid for by businesses and health plans to service their employees or members.
Who invested in Galileo
1 investor across 1 round
See all investors in Galileo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 24, 2019
Amount
Undisclosed
Investors
Questions about Galileo
Who invested in Galileo?
Galileo has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Galileo raised?
Galileo has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Galileo last raise money?
Galileo's most recent round on record is a Series A, in May 2019.
What does Galileo do?
Galileo is a healthcare it company.
Where is Galileo headquartered?
Galileo is headquartered in New York, US.
Which VCs invest in companies like Galileo?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at Galileo's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like Galileo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.